Article

Systematic druggable genome-wide Mendelian randomization identifies novel therapeutic targets or repurposing opportunities for rheumatoid arthritis

2023-10-18

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Rheumatoid arthritis (RA) is a common autoimmune inflammatory disease. Currently, a complete cure for RA is still unavailable. Mendelian randomization (MR) has emerged as a valuable tool for identifying potential therapeutic targets or drug repurposing opportunities for certain diseases. Therefore, our aim was to identify novel effective targets or drug repurposi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cf9ad302-e29e-5b12-b392-108ed315f893
DOI: 10.21203/rs.3.rs-3438026/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Systematic druggable genome-wide Mendelian randomization identifies novel therapeutic targets or repurposing opportunities for rheumatoid arthritisDOI 10.21203/rs.3.rs-3438026/v1Read

Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization studySemantic proximity Read

Integrative Analysis of Genetic, Proteomic, and Transcriptomic Data Reveals Novel Therapeutic Targets for Rheumatoid ArthritisSemantic proximity Read

Integrative analysis highlighted susceptibility genes for rheumatoid arthritis.Semantic proximity Read

Exploring inflammatory bowel disease therapy targets through druggability genes: a Mendelian randomization study.Semantic proximity Read

Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization.Semantic proximity Read

TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitroSemantic proximity Read

Genetics of rheumatoid arthritis contributes to biology and drug discovery.Semantic proximity Read

Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer’s disease risk: a pQTL-based Mendelian randomization and colocalization analysisSemantic proximity Read

Integrative Multiomics Network Analysis of Genetic Risk Factors to Infer Biomarkers and Therapeutic Targets for Rheumatoid ArthritisSemantic proximity Read

Exploring the therapeutic potential of interleukin-6 receptor blockade in autoimmune diseases using drug target mendelian randomization.Semantic proximity Read

A genomics-based systems approach towards drug repositioning for rheumatoid arthritis.Semantic proximity Read

Mendelian randomization analysis to identify potential drug targets for osteoarthritisSemantic proximity Read